Don't fall behind. Take a step toward becoming indispensable to your organization by attending our no-cost* LEAN Cell & Gene ...

The Lancet Haematology's Adverse Events Reporting Series scrutinises an overlooked aspect of clinical trials, emphasising ...

Aliyah Boston has been a machine since the All-Star break with four straight double-doubles, including a 22-point, 12-rebound night vs. Mercury.

Boston appears unique in focusing its regulatory proposals almost entirely on Waymo's impact on protecting the jobs of unionized drivers.

Aliyah Boston's new podcast "Post Moves" with WNBA legend Candace Parker is set to release its first episode on Wednesday. They wasted no time digging into one of the most viral moments from WNBA ...

GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that offered some respite after recent setbacks.

Looking ahead for fiscal 2025, GSK now expects core earnings per share and core operating profit to increase towards the top end of previous range of 6 percent to 8 percent, and turnover to grow ...

The FBI's Boston division is warning New Englanders about a rise in impersonation scams.

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

WHAT TO WATCH --GSK has guided for full-year sales to grow between 3% and 5% and its core operating profit to increase between 6% and 8% excluding currency movements.

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and inflammation.